CD4+ T cells can activate monocytes/macrophages, NK cells, and specific CD8+ cytotoxic T cells and are thus pivotal to the antitumor response, suggesting an explanation for the significant association between circulating CD4+ cells and OS previously demonstrated in some cancers [37]. Here, CD8A is linked to cancer.